摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-{acetyl-[(S)-1-(4-methoxy-phenyl)-ethyl]-amino}-N-benzyl-3-methoxy-propionamide | 1437318-02-9

中文名称
——
中文别名
——
英文名称
(R)-2-{acetyl-[(S)-1-(4-methoxy-phenyl)-ethyl]-amino}-N-benzyl-3-methoxy-propionamide
英文别名
(2R)-2-[acetyl-[(1S)-1-(4-methoxyphenyl)ethyl]amino]-N-benzyl-3-methoxypropanamide
(R)-2-{acetyl-[(S)-1-(4-methoxy-phenyl)-ethyl]-amino}-N-benzyl-3-methoxy-propionamide化学式
CAS
1437318-02-9
化学式
C22H28N2O4
mdl
——
分子量
384.475
InChiKey
CGUNDOJCNKEPAU-HRAATJIYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    128 °C(Solvent: Ethanol ; Water)
  • 沸点:
    600.4±55.0 °C(Predicted)
  • 密度:
    1.129±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    28
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    67.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (R)-2-{acetyl-[(S)-1-(4-methoxy-phenyl)-ethyl]-amino}-N-benzyl-3-methoxy-propionamide甲酸苯甲醚 作用下, 反应 1.0h, 以83%的产率得到拉克酰胺
    参考文献:
    名称:
    Development of Scalable Conditions for the Ugi Reaction—Application to the Synthesis of (R)-Lacosamide
    摘要:
    The Ugi reaction is applied for the preparation of (R)-lacosamide, an important drug for the treatment of epilepsy. To this end, key issues associated with the Ugi reaction, such as a practical preparation of the foul-smelling isocyanide as well as the efficient introduction of chirality via a cheap and easily removable chiral directing:group, were solved. Enantiomerically pure (>99.9% ee) drug substance meeting all required purity specifications is prepared in operationally simple four steps, in 40% overall yield from the commodity chemical benzylamine.
    DOI:
    10.1021/acs.oprd.5b00228
  • 作为产物:
    参考文献:
    名称:
    Development of Scalable Conditions for the Ugi Reaction—Application to the Synthesis of (R)-Lacosamide
    摘要:
    The Ugi reaction is applied for the preparation of (R)-lacosamide, an important drug for the treatment of epilepsy. To this end, key issues associated with the Ugi reaction, such as a practical preparation of the foul-smelling isocyanide as well as the efficient introduction of chirality via a cheap and easily removable chiral directing:group, were solved. Enantiomerically pure (>99.9% ee) drug substance meeting all required purity specifications is prepared in operationally simple four steps, in 40% overall yield from the commodity chemical benzylamine.
    DOI:
    10.1021/acs.oprd.5b00228
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS FOR THE PRODUCTION OF N-SUBSTITUTED 2-(ACETYLAMINO)-N'-BENZYL-3-METHOXYPROPANAMIDES<br/>[FR] PROCÉDÉ POUR LA PRODUCTION DE 2-(ACÉTYLAMINO)-N'-BENZYL-3-MÉTHOXYPROPANAMIDES N-SUBSTITUÉS
    申请人:SANOFI AVENTIS DEUTSCHLAND
    公开号:WO2013072330A1
    公开(公告)日:2013-05-23
    A process for the production of N-substituted 2-(acetylamino)-N'-benzyl-3-methoxypropanamides and subsequent treatment with acids is described. This process can be used for the production of (R)-Lacosamide.
    描述了一种生产N-取代的2-(乙酰氨基)-N'-苄基-3-甲氧基丙酰胺并随后用酸处理的过程。该过程可用于生产(R)-拉考酰胺。
  • PROCESS FOR THE PRODUCTION OF N-SUBSTITUTED 2-(ACETYLAMINO)-N'-BENZYL-3-METHOXYPROPANAMIDES
    申请人:Sanofi-Aventis Deutschland GmbH
    公开号:EP2780318A1
    公开(公告)日:2014-09-24
  • EP2780318B1
    申请人:——
    公开号:EP2780318B1
    公开(公告)日:2015-08-26
  • Development of Scalable Conditions for the Ugi Reaction—Application to the Synthesis of (<i>R</i>)-Lacosamide
    作者:Hermut Wehlan、Jan Oehme、Alexander Schäfer、Kai Rossen
    DOI:10.1021/acs.oprd.5b00228
    日期:2015.12.18
    The Ugi reaction is applied for the preparation of (R)-lacosamide, an important drug for the treatment of epilepsy. To this end, key issues associated with the Ugi reaction, such as a practical preparation of the foul-smelling isocyanide as well as the efficient introduction of chirality via a cheap and easily removable chiral directing:group, were solved. Enantiomerically pure (>99.9% ee) drug substance meeting all required purity specifications is prepared in operationally simple four steps, in 40% overall yield from the commodity chemical benzylamine.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物